Who owns Cogent Biosciences, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of COGT from SEC Form 13F filings across 323 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 323 institutions disclosed 193.6M shares of Cogent Biosciences, Inc. worth $7.49B — about 113.2% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
323
13F holders
$7.49B
value, 2026 filers
113.2%
of shares outstanding (193.6M sh)
66
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of COGT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 25.7M | $993.9M | 0.0% | 15% | +11.1% |
| 2 | BlackRock, Inc. | 17.4M | $671.5M | 0.0% | 10.1% | +8.1% |
| 3 | VANGUARD PORTFOLIO MANAGEMENT LLC | 8.1M | $312.4M | 0.0% | 4.7% | +10.1% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 7.4M | $286.9M | 0.0% | 4.3% | +7.5% |
| 5 | STATE STREET CORP | 7.0M | $269.5M | 0.0% | 4.1% | +23.0% |
| 6 | Jupiter Topco LLCNEW | 6.6M | $256.4M | 0.1% | 3.9% | new |
| 7 | Fairmount Funds Management LLC | 5.5M | $213.0M | 14.1% | 3.2% | 0.0% |
| 8 | DEERFIELD MANAGEMENT COMPANY, L.P. | 5.0M | $193.7M | 2.0% | 2.9% | -44.6% |
| 9 | TCG Crossover Management, LLC | 4.9M | $187.9M | 4.5% | 2.8% | -1.9% |
| 10 | PRICE T ROWE ASSOCIATES INC /MD/ | 4.7M | $180.1M | 0.0% | 2.7% | +44.8% |
| 11 | GEODE CAPITAL MANAGEMENT, LLC | 4.5M | $174.5M | 0.0% | 2.6% | +21.9% |
| 12 | WELLINGTON MANAGEMENT GROUP LLP | 4.3M | $168.1M | 0.0% | 2.5% | +21.4% |
| 13 | Kynam Capital Management, LP | 3.7M | $141.9M | 7.8% | 2.1% | -9.2% |
| 14 | LORD, ABBETT & CO. LLC | 3.4M | $132.8M | 0.4% | 2% | +7.9% |
| 15 | Polar Capital Holdings PlcNEW | 3.2M | $125.1M | 0.3% | 1.9% | new |
| 16 | Commodore Capital LP | 3.0M | $118.0M | 7.0% | 1.8% | +5.6% |
| 17 | Invesco Ltd. | 2.6M | $101.0M | 0.0% | 1.5% | +7.4% |
| 18 | Woodline Partners LP | 2.6M | $100.7M | 0.3% | 1.5% | +72.4% |
| 19 | Pictet Asset Management Holding SA | 2.4M | $92.6M | 0.1% | 1.4% | +33.1% |
| 20 | Octagon Capital Advisors LP | 2.4M | $90.9M | 8.2% | 1.4% | 0.0% |
| 21 | RTW INVESTMENTS, LP | 2.3M | $89.4M | 0.8% | 1.4% | -57.7% |
| 22 | GOLDMAN SACHS GROUP INC | 2.3M | $88.6M | 0.0% | 1.3% | -48.4% |
| 23 | Candriam S.C.A. | 2.1M | $80.7M | 0.4% | 1.2% | +37.7% |
| 24 | Deep Track Capital, LP | 2.0M | $77.4M | 1.1% | 1.2% | +100.0% |
| 25 | Siren, L.L.C. | 1.9M | $72.0M | 1.5% | 1.1% | +8.8% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.